Join
Live feed
·
INSIDERFilingvia Quantisnow
Protagenic Therapeutics Inc. logo

SEC Form 4: Arrow Alexander K. bought $22,090 worth of PTIX Common Stock (31,000 units at $0.71), increasing direct ownership by 26% to 151,260 units

ByQuantisnow·Wall Street's wire, on your screen.
PTIX· Protagenic Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTIX (Protagenic Therapeutics Inc.) and more on Quantisnow.